With the recent report in The Lancet that the number of overweight and obese people on the planet has topped 2.1 billion, this week’s Homerun Slides will give you a closer look at the issue in some specific countries as well as the importance of taking action sooner rather than …

Richard S. Beaser, MD This week’s excerpt covers the following topics: Drug interactions with potential for clinical significance for metformin Contraindications and precautions for metformin Class contraindications and precautions for TZD’s Which TZD interactions are serious and how it is metabolized  

US Department of Veterans Affairs iOS Free    For your patients who are veterans, the U.S. Departments of Veterans Affairs has recently begun releasng several apps designed to both help vets in their personal health goals and also navigate the VA system. (For the complete of what’s available and what’s …

This week there is a great item about diabetes and cardiovascular problems, especially in women. In fact there are a total of four items that continue to expound on the relationship between diabetes, obesity and cardiovascular Disease. To make matters worse, many patients who have had a heart attack and …

Heart Risk and Death 44% Greater for Women with Diabetes See this week’s Item #1.

How to Establish Glucose Targets to Achieve A1c Goals(pdf)  Now you have an answer for your patients who ask, “What do my blood sugars have to be after meals, before meals, and at bedtime to get an A1c of 5.5%?” The ADAG study was able to determine the average blood …

HealthSpot Stations  Cleveland Clinic and HealthSpot are forming a joint venture that will offer patients convenient, alternative options to access health care through HealthSpot’s virtual walk-in kiosks. HealthSpot stations — private, 8-by-5-foot enclosures outfitted with touch screens, integrated medical devices and videoconferencing capabilities — will enable Cleveland Clinic medical providers …

Cleveland Clinic and HealthSpot are looking to form a joint venture that will offer patients convenient, alternative options to access health care through HealthSpot’s virtual walk-in kiosks.

Research published in Diabetes Care in February found that while most health groups advise diabetes patients to target fasting blood glucose rates lower than 120 mg/dL, the actual mean fasting glucose level was higher in those whose A1C rates ranged between 5.5% and 6.99%. "Considering the safety concerns surrounding hypoglycemia, the current …

The European Commission has approved empagliflozin 10 mg and 25 mg once-daily tablets for use in adults when glycemic control is not achieved from diet and exercise. The European Commission endorsed empagliflozin for approval in March after the U.S. FDA delayed the approval and requested more data. A new drug …